Hannah E. Gautrey
Newcastle Upon Tyne, ENG NE128ET, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Development of a Novel IHC Assay for PD-L1 Detection in Non-Small Cell Lung Cancer.
Journal: Biomedicines
Published: July 28, 2025
HER2-PI9 and HER2-I12: two novel and functionally active splice variants of the oncogene HER2 in breast cancer.
Journal: Journal of cancer research and clinical oncology
Published: May 10, 2021
Regulation of Mcl-1 alternative splicing by hnRNP F, H1 and K in breast cancer cells.
Journal: RNA biology
Published: November 24, 2018
How is Herstatin, a tumor suppressor splice variant of the oncogene HER2, regulated?
Journal: RNA biology
Published: December 10, 2016
SRSF3 and hnRNP H1 regulate a splicing hotspot of HER2 in breast cancer cells.
Journal: RNA biology
Published: September 15, 2015
Unravelling the RNA-Binding Properties of SAFB Proteins in Breast Cancer Cells.
Journal: BioMed research international
Published: January 29, 2015
Deregulation of splicing factors and breast cancer development.
Journal: Journal of molecular cell biology
Published: December 15, 2014
The HER2 Signaling Network in Breast Cancer--Like a Spider in its Web.
Journal: Journal of mammary gland biology and neoplasia
Published: November 18, 2014
Clinical Significance of HER-2 Splice Variants in Breast Cancer Progression and Drug Resistance.
Journal: International journal of cell biology
Published: June 06, 2013
Epigenetic inactivation of TWIST2 in acute lymphoblastic leukemia modulates proliferation, cell survival and chemosensitivity.
Journal: Haematologica
Published: November 08, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026